Predicting Survival Outcome of Localized Melanoma: An Electronic Prediction Tool Based on the AJCC Melanoma Database
We sought to develop a reliable and reproducible statistical model to predict the survival outcome of patients with localized melanoma.
A total of 25,734 patients with localized melanoma from the 2008 American Joint Committee on Cancer (AJCC) Melanoma Database were used for the model development and validation. The predictive model was developed from the model development data set (n = 14,760) contributed by nine major institutions and study groups and was validated on an independent model validation data set (n = 10,974) consisting of patients from a separate melanoma center. Multivariate analyses based on the Cox model were performed for the model development, and the concordance correlation coefficients were calculated to assess the adequacy of the predictive model.
Patient characteristics in both data sets were virtually identical, and tumor thickness was the single most important prognostic factor. Other key prognostic factors identified by stratified analyses included ulceration, lesion site, and patient age. Direct comparisons of the predicted 5- and 10-year survival rates calculated from the predictive model and the observed Kaplan-Meier 5- and 10-year survival rates estimated from the validation data set yielded high concordance correlation coefficients of 0.90 and 0.93, respectively. A Web-based electronic prediction tool was also developed (http://www.melanomaprognosis.org/).
This is the first predictive model for localized melanoma that was developed based on a very large data set and was successfully validated on an independent data set. The high concordance correlation coefficients demonstrated the accuracy of the predicted model. This predictive model provides a clinically useful tool for making treatment decisions, for assessing patient risk, and for planning and analyzing clinical trials.
- 3.Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery. 1980;86:343–51.Google Scholar
- 10.Morton DL, Davtyan DG, Wanek LA, et al. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer. 1993;71:3737.Google Scholar
- 13.Gershenwald JE, Balch CM, Soong SJ, Thompson JF. Prognostic factors and natural history. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF, editors. Cutaneous melanoma. 5th ed. St Louis, MO: Quality Medical Publishing; 2009. p. 35–64.Google Scholar
- 14.Balch CM, Milton GW, Shaw HM, Soong SJ, eitors. Cutaneous melanoma: clinical management and treatment results worldwide. Philadelphia: Lippincott; 1985.Google Scholar
- 15.Soong SJ. A computerized mathematical model and scoring system for predicting outcome in melanoma patients. In: Balch CM, Milton GW, editors. Cutaneous melanoma: clinical management and treatment results worldwide. Philadelphia: Lippincott; 1985. p. 353.Google Scholar
- 21.Soong SJ, Zhang Y, Desmond R. Models for predicting outcome. In: Balch CM, Houghton AN, Sober A, Soong SJ, editors. Cutaneous melanoma. 4th ed. St. Louis: Quality Medical Publishing; 2003. p. 77–90.Google Scholar
- 26.Cox DR. Regression models and life tables. J R Statist Soc. 1972;B34:187.Google Scholar